Skip to main content

Trevi Therapeutics, Inc.

TRVI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001563880

In the last 90 days, Trevi Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 218 institutions reported holding it in 13F filings for Q2 2026, worth $2.76B in total; Viking Global Investors is the only superinvestor holding it.

Q3 2025 vs. Q2 2025

How the institutions holding Trevi Therapeutics, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of TRVI: Q2 2025 compared with Q3 2025
MeasureQ2 2025Of which not filed for Q3 2025Q3 2025Change
Holders1541164+11
Shares114.7M500129.3M+14.7M (+12.8%)
Value$627.2M$2.73K$1.18B+$556.1M (+88.7%)

1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (35)

Institutions that held Trevi Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to TRVI in Q3 2025
InstitutionSharesValue% of portfolio
Peregrine Capital Management LLC620,464$5.68M0.17%
StemPoint Capital LP350,710$3.21M0.65%
Velan Capital Investment Management LP205,000$1.88M1.76%
Swiss National Bank161,700$1.48M0.00%
UBS Asset Management Americas Inc116,477$1.07M0.00%
Nan Fung Trinity (HK) Ltd89,575$819.6K0.08%
SEI Investments Co85,798$785.1K0.00%
Capstone Investment Advisors, LLC73,287$670.6K0.01%
SG Americas Securities, LLC64,545$591.0K0.00%
Simplex Trading, LLC63,149$577.0K0.01%
Optimize Financial Inc60,599$554.5K0.29%
DLD Asset Management, LP55,000$503.3K0.06%
Gsa Capital Partners LLP43,506$398.0K0.03%
Janus Henderson Group PLC37,127$339.9K0.00%
Chapin Davis, Inc.35,100$321.2K0.08%
Readystate Asset Management LP34,399$314.8K0.02%
IMC-Chicago, LLC30,602$280.0K0.00%
Harbour Capital Advisors, LLC27,500$262.6K0.05%
Arizona State Retirement System24,662$225.7K0.00%
Teacher Retirement System of Texas20,219$185.0K0.00%
KLP Kapitalforvaltning AS17,400$159.2K0.00%
Pictet Asset Management Holding SA11,259$103.0K0.00%
Quest Partners LLC8,697$79.6K0.01%
REAP Financial Group, LLC2,000$18.3K0.00%
Optiver Holding B.V.888$8.13K0.00%
Quadrant Capital Group LLC789$7.22K0.00%
Signaturefd, LLC674$6.17K0.00%
SRS Capital Advisors, Inc.185$1.69K0.00%
SBI Securities Co., Ltd.117$1.07K0.00%
Allworth Financial LP53$4850.00%
Clearstead Advisors, LLC39$3570.00%
Essential Partners LLC11$1010.00%
US Bancorp4$370.00%
Larson Financial Group LLC3$270.00%
Smartleaf Asset Management LLC1$80.00%

Sold out (24)

Institutions that held Trevi Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Not filed for Q3 2025 yet (1)

Institutions that held Trevi Therapeutics, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TRVI in Q2 2025 that haven't filed for Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
First Horizon Advisors, Inc.500$2.73K